International
Clinical Validation Test for CISH Applied Spectral Imaging is recruiting a pathology lab to participate in a clinical validation study for HER2 CISH testing. The objective of this study is to evaluate the success of ASI’s GenASIs HiPath...
microDimensions is pleased to exhibit at the European Congress on Digital Pathology in Paris (ECDP) and the Society of Toxicologic Pathology’s Symposium in Washington D.C. (STP) We would be happy to welcome you at our booth! ECDP –...
microDimensions is pleased to announce their attendance as Hamamatsu’s co-exhibitor at the 98. Jahrestagung der DGP (Deutsche Gesellschaft für Pathologie). We recommend you take time to visit us! DGP – Berlin, June 13 – 14,...
Conference website Global Engage is pleased to announce their inaugural Digital Pathology Congress which will be held on December 4-5 in London, UK. The conference is part of their successful Drug Discovery series which includes events...
Courtesy of GE Reports: Will Digital Pathology Retire the Microscope? Pathologists are doctors and scientists who study tissue, blood and other biological specimens to find the cause of illness and a route to treatment. Many of them still...
Join Visiopharm for our webinar, “HER2 Protein Expression in Breast Cancer: Membrane Morphology and Accuracy with Regard to Gene Amplification” presented by Michael Grunkin, PhD the CEO and co-founder of Visiopharm. Date: Monday,...
